Benitec Biopharma, Inc. (BNTC)
8.98
-0.60
(-6.26%)
USD |
NASDAQ |
Oct 02, 16:00
8.95
-0.03
(-0.33%)
After-Hours: 20:00
Benitec Biopharma Market Cap : 309.06M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 309.06M |
| October 01, 2026 | 329.71M |
| September 30, 2026 | 344.17M |
| September 29, 2026 | 335.56M |
| September 28, 2026 | 344.86M |
| September 25, 2026 | 330.06M |
| September 24, 2026 | 331.78M |
| September 23, 2026 | 338.32M |
| September 22, 2026 | 376.86M |
| September 21, 2026 | 374.45M |
| September 18, 2026 | 379.27M |
| September 17, 2026 | 390.97M |
| September 16, 2026 | 379.96M |
| September 15, 2026 | 380.31M |
| September 14, 2026 | 415.75M |
| September 11, 2026 | 419.54M |
| September 10, 2026 | 420.57M |
| September 09, 2026 | 427.71M |
| September 08, 2026 | 437.16M |
| September 04, 2026 | 435.61M |
| September 03, 2026 | 427.37M |
| September 02, 2026 | 442.48M |
| September 01, 2026 | 422.90M |
| August 31, 2026 | 418.09M |
| August 28, 2026 | 428.40M |
| Date | Value |
|---|---|
| August 27, 2026 | 435.27M |
| August 26, 2026 | 442.48M |
| August 25, 2026 | 447.29M |
| August 24, 2026 | 436.64M |
| August 21, 2026 | 463.10M |
| August 20, 2026 | 446.95M |
| August 19, 2026 | 459.66M |
| August 18, 2026 | 442.48M |
| August 17, 2026 | 449.01M |
| August 14, 2026 | 431.49M |
| August 13, 2026 | 431.49M |
| August 12, 2026 | 423.93M |
| August 11, 2026 | 463.10M |
| August 10, 2026 | 473.40M |
| August 07, 2026 | 468.25M |
| August 06, 2026 | 451.07M |
| August 05, 2026 | 435.96M |
| August 04, 2026 | 430.12M |
| August 03, 2026 | 417.40M |
| July 31, 2026 | 402.29M |
| July 30, 2026 | 407.44M |
| July 29, 2026 | 413.97M |
| July 28, 2026 | 408.47M |
| July 27, 2026 | 397.82M |
| July 24, 2026 | 394.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| Price to Book Value | 1.746 |
| Price | 8.98 |
| Earnings Yield | -12.11% |